LEGAL REFERENCES

REGULATORY INFORMATION

Adcock Ingram Limited. Co. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, 2021, South Africa. Customer Care: 0860 ADCOCK/232625. www.adcock.co.za.

ActiPatch: ActiPatch^® is a registered trademark of BioElectronics Corporation. For full prescribing information refer to the Instructions for Use.

Adco-Mayogel: S0 Adco-Mayogel^® Suspension. Each 15 ml contains aluminium hydroxide gel dried equivalent to aluminium oxide 282,00 mg; magnesium trisilicate equivalent to magnesium oxide 120,00 mg. Reg. No. No. E/11.4.1/1732. (PI 07/2023). For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Adco-Napamol: S0 Adco-Napamol® Tablets. Each tablet contains paracetamol 500 mg. Reg. No. B/2.7/1404. (PI 09/2021). S0 Adco-Napamol® Elixir. Each 5ml contains paracetamol 120 mg. Reg. No. B/2.7/1409. (PI 04/1991). For full prescribing information refer to the Professional Information approved by the Medicine Regulatory Authority.

Allergex Non Drowsy: S1 Allergex® Non Drowsy Tablets. Each tablet contains loratadine (micronised) 10 mg. Reg. No. 36/5.7.1/0286. (PI 11/2021) S1 Allergex® Non Drowsy Syrup. Each 5 ml contains loratadine (micronised) 5 mg. Reg. No. 36/5.7.1/0008 (PI 01/2023). For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Citro-Soda: S0 Citro-Soda®. Each 4 g contains sodium bicarbonate 1716 mg, tartaric acid 858 mg, citric acid 702 mg, sodium citrate 613 mg. Reg. No. E1031 (Act 101/1965) (PI 06/2023). S0 Citro-Soda® Cranberry. Each 4 g contains sodium bicarbonate 1716 mg, tartaric acid 858 mg, citric acid 702 mg, sodium citrate 613 mg. Reg. No. 28/18.3/0372. (PI 07/2006). For full Professional Information refer to the professional information approved by the medicines regulatory authority.

Corenza Para-C: S1 Corenza Para-C Effervescent Tablets. Each tablet contains: paracetamol 650 mg, phenylephrine HCI 10 mg, vitamin C 250 mg. Reg. No. 29/5.8/0657. (PI 11/1995). For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Dilinct^® Junior: S0 Dilinct® Junior. Each 10 ml syrup contains guaifenesin 200 mg. Reg. No. 33/10.1/0086. (PI 10/2000). For full prescribing information refer to the package insert approved by the medical regulatory authority.

Expigen: S0 Expigen® Cough. Each 10 ml syrup contains sorbimacrogol laurate 300 36,33 mg; ammonium chloride 34 mg. Reg. No. E/10.1/21. (PI 12/1987). Trademark under licence from Kabi Pharmacia AB, Uppsala. For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Medi-Keel A: S1 Medi-Keel A® Throat Lozenges. Each lozenge contains benzocaine 12,0 mg, cetylpyridinium chloride 1,5 mg. Reg. No. T/16.3/223. (PI 07/1986). S0 Medi-Keel A® Throat Spray. Each 100 ml contains phenol 0,5 mg. Reg. No. T/16.4/184. For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Nazene Z: S1 Nazene Z Nasal Spray. A16.1. Each 1 ml spray contains oxymetazoline hydrochloride 0,5 mg; zinc sulphate 0,015 mg. Ref. No. H1501 (Act 101/1965) (PI 02/1975). S1 Nazene Adult Nasal Metered Spray. Each 1 ml of the solution contains oxymetazoline hydrochloride 0,50 mg. Reg. No. A39/16.1/0211. (PI 02/2006). For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Scopex: S1 Scopex® Tablets. Each tablet contains hyoscine-N-butylbromide 10 mg. Ref. No. C674 (Act 101/1965) (PI 09/2021). S1 Scopex® Syrup. Each 5 ml of syrup contains hyoscine butylbromide 5 mg. Reg. No. 36/11.2/0327. (PI 06/2021). For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Tellerge: S1 Tellerge 120 mg. Each tablet contains 120 mg of fexofenadine hydrochloride. Reg. No. 41/5.7.1/0352. S1 Tellerge 180 mg. Each tablet contains 180 mg of fexofenadine hydrochloride. Reg. No. 41/5.7.1/0353. (PI 08/2020). For full prescribing information refer to the Professional Information insert approved by the medicines regulatory authority.

MEDICAL REFERENCES

1. ActiPatch® Directions For Use, March 2021.
2. Adco-Mayogel® Professional Information, July 2023.
3. Adco-Napamol® Tablets & Elixir Professional Information, September 2021.
4. Allergex® Non Drowsy Tablets Professional Information, November 2021.
5. Allergex® Non Drowsy Syrup Professional Information, January 2003.
6. Citro-Soda® Professional Information, June 2023.
7. Corenza Para-C Effervescent Tablets Professional Information, November 1995.
8. Dilinct® Junior package insert, October 2010.
9. Expigen® Cough package insert, December 1987.
10. Medi-Keel A® Throat Lozenges package insert, July 1987.
11. Medi-Keel A® Throat Spray package insert, April 2019.
12. Nazene Z Nasal Spray package insert, February 2006.
13. Scopex® Tablets Professional Information, September 2021.
14. Scopex® Syrup Professional Information, June 2021.
15. Tellerge Professional Information, August 2020.